References
- AkiraSTakedaKKaishoTToll-like receptors: critical proteins linking innate and acquired immunityNat Immunol20012867568011477402
- DuXPoltorakAWeiYBeutlerBThree novel mammalian toll-like receptors: gene structure, expression, and evolutionEur Cytokine Netw200011336237111022119
- ChuangTHUlevitchRJCloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9Eur Cytokine Netw200011337237811022120
- TabetaKGeorgelPJanssenEToll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infectionProc Natl Acad Sci U S A2004101103516352114993594
- KumagaiYTakeuchiOAkiraSPathogen recognition by innate receptorsJ Infect Chemother2008142869218622669
- IwasakiAMedzhitovRToll-like receptor control of the adaptive immune responsesNat Immunol200451098799515454922
- KutikhinAGAssociation of polymorphisms in TLR genes and in genes of the toll-like receptor signaling pathway with cancer riskHum Immunol201172111095111621872627
- ChangZLImportant aspects of toll-like receptors, ligands and their signaling pathwaysInflamm Res2010591079180820593217
- Rakoff-NahoumSMedzhitovRToll-like receptors and cancerNat Rev Cancer200991576319052556
- SoEYOuchiTThe application of toll like receptors for cancer therapyInt J Biol Sci20106767568121060729
- PandeySAgrawalDKImmunobiology of toll-like receptors: emerging trendsImmunol Cell Biol200684433334116834572
- PandeySMittalBSrivastavaMEvaluation of toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibilityMol Biol Rep20113874715472121132533
- O’NeillLABryantCEDoyleSLTherapeutic targeting of toll-like receptors for infectious and inflammatory diseases and cancerPharmacol Rev200961217719719474110
- RahmanAHTaylorDKTurkaLAThe contribution of direct TLR signaling to T cell responsesImmunol Res2009451253619597998
- SinghVSrivastavaNKapoorRMittalRDSingle-nucleotide polymorphisms in genes encoding toll-like receptor-2, -3, -4, and -9 in a case–control study with bladder cancer susceptibility in a North Indian populationArch Med Res2013441546123142523
- MandalRKGeorgeGPMittalRDAssociation of toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian populationMol Biol Rep20123977263726922311043
- ZhengSLAugustsson-BalterKChangBSequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the cancer prostate in Sweden studyCancer Res20046482918292215087412
- De MarzoAMPlatzEASutcliffeSInflammation in prostate carcinogenesisNat Rev Cancer20077425626917384581
- MiedemaKGTissingWJTe PoeleEMPolymorphisms in the TLR6 gene associated with the inverse association between childhood acute lymphoblastic leukemia and atopic diseaseLeukemia20122661203121022134717
- XieJJJiangSYShiMMThe association between toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibilityBMC Cancer2012125722309608
- KupcinskasJWexTBornscheinJLack of association between gene polymorphisms of angiotensin converting enzyme, Nod-like receptor 1, toll-like receptor 4 and Fas/Fasl with the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in CaucasiansHelicobacter201112112
- HoldGLRabkinCSGammonMDCD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populationsEur J Cancer Prev200918211711919337058
- RoszakALianeriMSowinskaAJagodzinskiPPErratum to: involvement of toll-like receptor 9 polymorphism in cervical cancer development (vol 39, p. 8425, 2012)Mol Biol Rep2013401731
- MollakiVGeorgiadisTTassidouAPolymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin’s lymphoma: a candidate-gene association studyJ Hum Genet2009541165565919745833
- EtokebeGEKnezevicJPetricevicBPavelicJVrbanecDDembicZSingle-nucleotide polymorphisms in genes encoding toll-like receptor-2,-3,-4, and -9 in case-control study with breast cancerGenet Test Mol Biomarkers200913672973419810822
- NoackJJordiMZaunerLTLR9 agonists induced cell death in Burkitt’s lymphoma cells is variable and influenced by TLR9 polymorphismCell Death Dis20123e32322717578
- CarvalhoACunhaCAlmeidaAJThe rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphomaGenes Immun201213219720121866115
- AshtonKAProiettoAOttonGToll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer riskBMC Cancer20101038220646321
- RahmanHAKhorshiedMMKhorshidOMMahgoubSMToll-like receptor 2 and 9 genetic polymorphisms and the susceptibility to B cell non-Hodgkin lymphoma in EgyptAnn Hematol201493111859186524912772
- ZhangLQinHGuanXZhangKLiuZThe TLR9 gene polymorphisms and the risk of cancer: evidence from a meta-analysisPloS one201388e7178523990988
- SemlaliAReddy ParineNArafahMExpression and polymorphism of toll-like receptor 4 and effect on NF-kappaB mediated inflammation in colon cancer patientsPLoS One2016111e014633326771524
- SemlaliAJacquesEPlanteSTGF-beta suppresses EGF-induced MAPK signaling and proliferation in asthmatic epithelial cellsAm J Respir Cell Mol Biol200838220220817872498
- SemlaliALeungKPCurtSRouabhiaMAntimicrobial decapeptide KSL-W attenuates Candida albicans virulence by modulating its effects on toll-like receptor, human beta-defensin, and cytokine expression by engineered human oral mucosaPeptides201132585986721291939
- AlanaziMPathanAAAbduljaleelZAssociation between PARP-1 V762A polymorphism and breast cancer susceptibility in Saudi populationPLoS One2013812e8554124392019
- BainesJCelisEImmune-mediated tumor regression induced by CpG-containing oligodeoxynucleotidesClin Cancer Res2003972693270012855649
- TuomelaJSandholmJKarihtalaPLow TLR9 expression defines an aggressive subtype of triple-negative breast cancerBreast Cancer Res Treat2012135248149322847512
- MarinoMXenoestrogens challenge 17β-estradiol protective effects in colon cancerWorld J Gastrointest Oncol201463677324653796
- BarziALenzAMLabonteMJLenzHJMolecular pathways: estrogen pathway in colorectal cancerClin Cancer Res201319215842584823965904
- al-AzzawiFWahabMEstrogen and colon cancer: current issuesClimacteric20025131411974557
- HendrickseCWJonesCEDonovanIANeoptolemosJPBakerPROestrogen and progesterone receptors in colorectal cancer and human colonic cancer cell linesBr J Surg19938056366408518910
- Valencia-SanchezMALiuJDHannonGJParkerRControl of translation and mRNA degradation by miRNAs and siRNAsGenes Dev200620551552416510870
- LiHZhaoHYuJIncreased prevalence of regulatory T cells in the lung cancer microenvironment: a role of thymic stromal lymphopoietinCancer Immunol Immunother201160111587159621681373
- SemlaliAAl AmriAAzziAExpression and new exon mutations of the human beta defensins and their association on colon cancer developmentPLoS One2015106e012686826038828
- LemosBBettencourtBRMeiklejohnCDHartlDLEvolution of proteins and gene expression levels are coupled in Drosophila and are independently associated with mRNA abundance, protein length, and number of protein-protein interactionsMol Biol Evol20052251345135415746013
- NuzhdinSVWayneMLHarmonKLMcIntyreLMCommon pattern of evolution of gene expression level and protein sequence in DrosophilaMol Biol Evol20042171308131715034135